CP and COVID-19: Conversely, Li et al. demonstrated an increase in Spike and RBD antibodies but not in Nucleocapsid antibodies in 10 patients who received CP [30], in conflict with both our findings and those of a recent study by Arrieta et al., which showed a significant increase in Nucleocapsid antibodies following CP infusion in 10 children with moderate COVID-19 [31].